カテゴリー： GlobalInfoResearch, 世界

オーダメイド医療およびエピゲノミクスの世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9102036）
◆英語タイトル：Global Personalized Medicine and Epigenomics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9102036
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：136
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートは、オーダメイド医療およびエピゲノミクスの世界市場について調べ、まとめました。種類別セグメントは、試薬、キット、機器、酵素、サービス等、用途別セグメントは、腫瘍学、非腫瘍学、がん治療技術等に区分しました。オーダメイド医療およびエピゲノミクスの世界市場概観、企業動向、企業別オーダメイド医療およびエピゲノミクスシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・オーダメイド医療およびエピゲノミクスの市場概観
・オーダメイド医療およびエピゲノミクスの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・オーダメイド医療およびエピゲノミクスの企業別販売動向、市場シェア、市場集中度、競争動向
・オーダメイド医療およびエピゲノミクスの世界市場規模
・オーダメイド医療およびエピゲノミクスの北米市場分析（アメリカ、カナダ、メキシコ等）
・オーダメイド医療およびエピゲノミクスのアメリカ市場規模推移
・オーダメイド医療およびエピゲノミクスのカナダ市場規模推移
・オーダメイド医療およびエピゲノミクスのメキシコ市場規模推移
・オーダメイド医療およびエピゲノミクスのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・オーダメイド医療およびエピゲノミクスのドイツ市場規模推移
・オーダメイド医療およびエピゲノミクスのイギリス市場規模推移
・オーダメイド医療およびエピゲノミクスのロシア市場規模推移
・オーダメイド医療およびエピゲノミクスのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・オーダメイド医療およびエピゲノミクスの日本市場規模推移
・オーダメイド医療およびエピゲノミクスの中国市場規模推移
・オーダメイド医療およびエピゲノミクスの韓国市場規模推移
・オーダメイド医療およびエピゲノミクスのインド市場規模推移
・オーダメイド医療およびエピゲノミクスの東南アジア市場規模推移
・オーダメイド医療およびエピゲノミクスの南米市場分析（ブラジル、アルゼンチン等）
・オーダメイド医療およびエピゲノミクスの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・オーダメイド医療およびエピゲノミクスの種類別分析/販売量、売上、市場シェア（試薬、キット、機器、酵素、サービス）
・オーダメイド医療およびエピゲノミクスの用途別分析/市場規模（腫瘍学、非腫瘍学、がん治療技術）
・オーダメイド医療およびエピゲノミクスの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・オーダメイド医療およびエピゲノミクスの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.

Scope of the Report:
The global Personalized Medicine and Epigenomics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Personalized Medicine and Epigenomics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Personalized Medicine and Epigenomics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Personalized Medicine and Epigenomics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Abbott Laboratories
Affymetrix
Agilent Technologies
Astellas Pharmaceuticals
BAYER AG
Bio Vision
Celgene Corp.
Emd Millipore
Epigenomics AG
Epigentex
Envivo Pharmaceuticals (Forum Pharmaceutricals)
Gilead Sciences
Glaxosmithkline
Illumina Inc.
Johnson & Johnson
Karus Therapeutics Limited
Laboratory Corp. Of America Holdings
LES Laboratoires Servier
Merck
Naturewise Biotech & Medicals Corp.
Novartis Pharma AG
Oncolys Biopharma Inc.
Orchid Chemicals & Pharmaceuticals Limited
Progen Pharmaceuticals Limited
Quest Diagnostics
Roche Holding AG
Rubicon Genomics
Takeda Pharmaceutical Company Limited

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Reagents
Kits
Instruments
Enzymes
Services

Market Segment by Applications, can be divided into
Oncology
Non-Oncology
Cancer Drug Technology

【レポートの目次】

Table of Contents

1 Personalized Medicine and Epigenomics Market Overview
1.1 Product Overview and Scope of Personalized Medicine and Epigenomics
1.2 Classification of Personalized Medicine and Epigenomics by Types
1.2.1 Global Personalized Medicine and Epigenomics Revenue Comparison by Types (2019-2024)
1.2.2 Global Personalized Medicine and Epigenomics Revenue Market Share by Types in 2018
1.2.3 Reagents
1.2.4 Kits
1.2.5 Instruments
1.2.6 Enzymes
1.2.7 Services
1.3 Global Personalized Medicine and Epigenomics Market by Application
1.3.1 Global Personalized Medicine and Epigenomics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Oncology
1.3.3 Non-Oncology
1.3.4 Cancer Drug Technology
1.4 Global Personalized Medicine and Epigenomics Market by Regions
1.4.1 Global Personalized Medicine and Epigenomics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Personalized Medicine and Epigenomics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Personalized Medicine and Epigenomics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Personalized Medicine and Epigenomics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Personalized Medicine and Epigenomics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Personalized Medicine and Epigenomics Status and Prospect (2014-2024)
1.5 Global Market Size of Personalized Medicine and Epigenomics (2014-2024)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Personalized Medicine and Epigenomics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Affymetrix
2.2.1 Business Overview
2.2.2 Personalized Medicine and Epigenomics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Affymetrix Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Agilent Technologies
2.3.1 Business Overview
2.3.2 Personalized Medicine and Epigenomics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Agilent Technologies Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.4 Astellas Pharmaceuticals
2.4.1 Business Overview
2.4.2 Personalized Medicine and Epigenomics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.5 BAYER AG
2.5.1 Business Overview
2.5.2 Personalized Medicine and Epigenomics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BAYER AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bio Vision
2.6.1 Business Overview
2.6.2 Personalized Medicine and Epigenomics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio Vision Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Celgene Corp.
2.7.1 Business Overview
2.7.2 Personalized Medicine and Epigenomics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Celgene Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Emd Millipore
2.8.1 Business Overview
2.8.2 Personalized Medicine and Epigenomics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Emd Millipore Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Epigenomics AG
2.9.1 Business Overview
2.9.2 Personalized Medicine and Epigenomics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Epigenomics AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.10 Epigentex
2.10.1 Business Overview
2.10.2 Personalized Medicine and Epigenomics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Epigentex Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.11 Envivo Pharmaceuticals (Forum Pharmaceutricals)
2.11.1 Business Overview
2.11.2 Personalized Medicine and Epigenomics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.12 Gilead Sciences
2.12.1 Business Overview
2.12.2 Personalized Medicine and Epigenomics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Gilead Sciences Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.13 Glaxosmithkline
2.13.1 Business Overview
2.13.2 Personalized Medicine and Epigenomics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Glaxosmithkline Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.14 Illumina Inc.
2.14.1 Business Overview
2.14.2 Personalized Medicine and Epigenomics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Illumina Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.15 Johnson & Johnson
2.15.1 Business Overview
2.15.2 Personalized Medicine and Epigenomics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Johnson & Johnson Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.16 Karus Therapeutics Limited
2.16.1 Business Overview
2.16.2 Personalized Medicine and Epigenomics Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Karus Therapeutics Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.17 Laboratory Corp. Of America Holdings
2.17.1 Business Overview
2.17.2 Personalized Medicine and Epigenomics Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.18 LES Laboratoires Servier
2.18.1 Business Overview
2.18.2 Personalized Medicine and Epigenomics Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 LES Laboratoires Servier Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.19 Merck
2.19.1 Business Overview
2.19.2 Personalized Medicine and Epigenomics Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Merck Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.20 Naturewise Biotech & Medicals Corp.
2.20.1 Business Overview
2.20.2 Personalized Medicine and Epigenomics Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.21 Novartis Pharma AG
2.21.1 Business Overview
2.2.2 Personalized Medicine and Epigenomics Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Novartis Pharma AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.22 Oncolys Biopharma Inc.
2.22.1 Business Overview
2.22.2 Personalized Medicine and Epigenomics Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.23 Orchid Chemicals & Pharmaceuticals Limited
2.23.1 Business Overview
2.23.2 Personalized Medicine and Epigenomics Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.24 Progen Pharmaceuticals Limited
2.24.1 Business Overview
2.24.2 Personalized Medicine and Epigenomics Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.25 Quest Diagnostics
2.25.1 Business Overview
2.25.2 Personalized Medicine and Epigenomics Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Quest Diagnostics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.26 Roche Holding AG
2.26.1 Business Overview
2.26.2 Personalized Medicine and Epigenomics Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Roche Holding AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.27 Rubicon Genomics
2.27.1 Business Overview
2.27.2 Personalized Medicine and Epigenomics Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Rubicon Genomics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
2.28 Takeda Pharmaceutical Company Limited
2.28.1 Business Overview
2.28.2 Personalized Medicine and Epigenomics Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Personalized Medicine and Epigenomics Market Competition, by Players
3.1 Global Personalized Medicine and Epigenomics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Personalized Medicine and Epigenomics Players Market Share
3.2.2 Top 10 Personalized Medicine and Epigenomics Players Market Share
3.3 Market Competition Trend
4 Global Personalized Medicine and Epigenomics Market Size by Regions
4.1 Global Personalized Medicine and Epigenomics Revenue and Market Share by Regions
4.2 North America Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
4.3 Europe Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
4.5 South America Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
5 North America Personalized Medicine and Epigenomics Revenue by Countries
5.1 North America Personalized Medicine and Epigenomics Revenue by Countries (2014-2019)
5.2 USA Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
5.3 Canada Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
5.4 Mexico Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
6 Europe Personalized Medicine and Epigenomics Revenue by Countries
6.1 Europe Personalized Medicine and Epigenomics Revenue by Countries (2014-2019)
6.2 Germany Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
6.3 UK Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
6.4 France Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
6.5 Russia Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
6.6 Italy Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Personalized Medicine and Epigenomics Revenue by Countries
7.1 Asia-Pacific Personalized Medicine and Epigenomics Revenue by Countries (2014-2019)
7.2 China Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
7.3 Japan Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
7.4 Korea Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
7.5 India Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
8 South America Personalized Medicine and Epigenomics Revenue by Countries
8.1 South America Personalized Medicine and Epigenomics Revenue by Countries (2014-2019)
8.2 Brazil Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
8.3 Argentina Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
8.4 Colombia Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Personalized Medicine and Epigenomics by Countries
9.1 Middle East and Africa Personalized Medicine and Epigenomics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
9.3 UAE Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
9.4 Egypt Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
9.6 South Africa Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
10 Global Personalized Medicine and Epigenomics Market Segment by Type
10.1 Global Personalized Medicine and Epigenomics Revenue and Market Share by Type (2014-2019)
10.2 Global Personalized Medicine and Epigenomics Market Forecast by Type (2019-2024)
10.3 Reagents Revenue Growth Rate (2014-2024)
10.4 Kits Revenue Growth Rate (2014-2024)
10.5 Instruments Revenue Growth Rate (2014-2024)
10.6 Enzymes Revenue Growth Rate (2014-2024)
10.7 Services Revenue Growth Rate (2014-2024)
11 Global Personalized Medicine and Epigenomics Market Segment by Application
11.1 Global Personalized Medicine and Epigenomics Revenue Market Share by Application (2014-2019)
11.2 Personalized Medicine and Epigenomics Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2014-2019)
11.4 Non-Oncology Revenue Growth (2014-2019)
11.5 Cancer Drug Technology Revenue Growth (2014-2019)
12 Global Personalized Medicine and Epigenomics Market Size Forecast (2019-2024)
12.1 Global Personalized Medicine and Epigenomics Market Size Forecast (2019-2024)
12.2 Global Personalized Medicine and Epigenomics Market Forecast by Regions (2019-2024)
12.3 North America Personalized Medicine and Epigenomics Revenue Market Forecast (2019-2024)
12.4 Europe Personalized Medicine and Epigenomics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Personalized Medicine and Epigenomics Revenue Market Forecast (2019-2024)
12.6 South America Personalized Medicine and Epigenomics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Personalized Medicine and Epigenomics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Personalized Medicine and Epigenomics Picture
Table Product Specifications of Personalized Medicine and Epigenomics
Table Global Personalized Medicine and Epigenomics and Revenue (Million USD) Market Split by Product Type
Figure Global Personalized Medicine and Epigenomics Revenue Market Share by Types in 2018
Figure Reagents Picture
Figure Kits Picture
Figure Instruments Picture
Figure Enzymes Picture
Figure Services Picture
Table Global Personalized Medicine and Epigenomics Revenue (Million USD) by Application (2014-2024)
Figure Personalized Medicine and Epigenomics Revenue Market Share by Applications in 2018
Figure Oncology Picture
Figure Non-Oncology Picture
Figure Cancer Drug Technology Picture
Table Global Market Personalized Medicine and Epigenomics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2014-2024)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Personalized Medicine and Epigenomics Type and Applications
Table Abbott Laboratories Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Affymetrix Basic Information, Manufacturing Base and Competitors
Table Affymetrix Personalized Medicine and Epigenomics Type and Applications
Table Affymetrix Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies Personalized Medicine and Epigenomics Type and Applications
Table Agilent Technologies Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Astellas Pharmaceuticals Personalized Medicine and Epigenomics Type and Applications
Table Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table BAYER AG Basic Information, Manufacturing Base and Competitors
Table BAYER AG Personalized Medicine and Epigenomics Type and Applications
Table BAYER AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Bio Vision Basic Information, Manufacturing Base and Competitors
Table Bio Vision Personalized Medicine and Epigenomics Type and Applications
Table Bio Vision Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corp. Basic Information, Manufacturing Base and Competitors
Table Celgene Corp. Personalized Medicine and Epigenomics Type and Applications
Table Celgene Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Emd Millipore Basic Information, Manufacturing Base and Competitors
Table Emd Millipore Personalized Medicine and Epigenomics Type and Applications
Table Emd Millipore Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Epigenomics AG Basic Information, Manufacturing Base and Competitors
Table Epigenomics AG Personalized Medicine and Epigenomics Type and Applications
Table Epigenomics AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Epigentex Basic Information, Manufacturing Base and Competitors
Table Epigentex Personalized Medicine and Epigenomics Type and Applications
Table Epigentex Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Envivo Pharmaceuticals (Forum Pharmaceutricals) Basic Information, Manufacturing Base and Competitors
Table Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Type and Applications
Table Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Personalized Medicine and Epigenomics Type and Applications
Table Gilead Sciences Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table Glaxosmithkline Personalized Medicine and Epigenomics Type and Applications
Table Glaxosmithkline Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Illumina Inc. Basic Information, Manufacturing Base and Competitors
Table Illumina Inc. Personalized Medicine and Epigenomics Type and Applications
Table Illumina Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Personalized Medicine and Epigenomics Type and Applications
Table Johnson & Johnson Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Karus Therapeutics Limited Basic Information, Manufacturing Base and Competitors
Table Karus Therapeutics Limited Personalized Medicine and Epigenomics Type and Applications
Table Karus Therapeutics Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Laboratory Corp. Of America Holdings Basic Information, Manufacturing Base and Competitors
Table Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Type and Applications
Table Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table LES Laboratoires Servier Basic Information, Manufacturing Base and Competitors
Table LES Laboratoires Servier Personalized Medicine and Epigenomics Type and Applications
Table LES Laboratoires Servier Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Personalized Medicine and Epigenomics Type and Applications
Table Merck Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Naturewise Biotech & Medicals Corp. Basic Information, Manufacturing Base and Competitors
Table Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Type and Applications
Table Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Pharma AG Basic Information, Manufacturing Base and Competitors
Table Novartis Pharma AG Personalized Medicine and Epigenomics Type and Applications
Table Novartis Pharma AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Oncolys Biopharma Inc. Basic Information, Manufacturing Base and Competitors
Table Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Type and Applications
Table Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Orchid Chemicals & Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Type and Applications
Table Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Progen Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Type and Applications
Table Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table Quest Diagnostics Personalized Medicine and Epigenomics Type and Applications
Table Quest Diagnostics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Holding AG Basic Information, Manufacturing Base and Competitors
Table Roche Holding AG Personalized Medicine and Epigenomics Type and Applications
Table Roche Holding AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Rubicon Genomics Basic Information, Manufacturing Base and Competitors
Table Rubicon Genomics Personalized Medicine and Epigenomics Type and Applications
Table Rubicon Genomics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Type and Applications
Table Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Personalized Medicine and Epigenomics Revenue (Million USD) by Players (2014-2019)
Table Global Personalized Medicine and Epigenomics Revenue Share by Players (2014-2019)
Figure Global Personalized Medicine and Epigenomics Revenue Share by Players in 2017
Figure Global Personalized Medicine and Epigenomics Revenue Share by Players in 2018
Figure Global Top 5 Players Personalized Medicine and Epigenomics Revenue Market Share in 2018
Figure Global Top 10 Players Personalized Medicine and Epigenomics Revenue Market Share in 2018
Figure Global Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Personalized Medicine and Epigenomics Revenue (Million USD) by Regions (2014-2019)
Table Global Personalized Medicine and Epigenomics Revenue Market Share by Regions (2014-2019)
Figure Global Personalized Medicine and Epigenomics Revenue Market Share by Regions (2014-2019)
Figure Global Personalized Medicine and Epigenomics Revenue Market Share by Regions in 2018
Figure North America Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Europe Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure South America Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Table North America Personalized Medicine and Epigenomics Revenue by Countries (2014-2019)
Table North America Personalized Medicine and Epigenomics Revenue Market Share by Countries (2014-2019)
Figure North America Personalized Medicine and Epigenomics Revenue Market Share by Countries (2014-2019)
Figure North America Personalized Medicine and Epigenomics Revenue Market Share by Countries in 2018
Figure USA Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Canada Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Mexico Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Table Europe Personalized Medicine and Epigenomics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Personalized Medicine and Epigenomics Revenue Market Share by Countries (2014-2019)
Figure Europe Personalized Medicine and Epigenomics Revenue Market Share by Countries in 2018
Figure Germany Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure UK Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure France Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Russia Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Italy Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Personalized Medicine and Epigenomics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Personalized Medicine and Epigenomics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Personalized Medicine and Epigenomics Revenue Market Share by Countries in 2018
Figure China Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Japan Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Korea Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure India Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Table South America Personalized Medicine and Epigenomics Revenue by Countries (2014-2019)
Table South America Personalized Medicine and Epigenomics Revenue Market Share by Countries (2014-2019)
Figure South America Personalized Medicine and Epigenomics Revenue Market Share by Countries (2014-2019)
Figure South America Personalized Medicine and Epigenomics Revenue Market Share by Countries in 2018
Figure Brazil Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Argentina Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Colombia Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Personalized Medicine and Epigenomics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Personalized Medicine and Epigenomics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Personalized Medicine and Epigenomics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Personalized Medicine and Epigenomics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure UAE Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Egypt Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure Nigeria Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Figure South Africa Personalized Medicine and Epigenomics Revenue and Growth Rate (2014-2019)
Table Global Personalized Medicine and Epigenomics Revenue (Million USD) by Type (2014-2019)
Table Global Personalized Medicine and Epigenomics Revenue Share by Type (2014-2019)
Figure Global Personalized Medicine and Epigenomics Revenue Share by Type (2014-2019)
Figure Global Personalized Medicine and Epigenomics Revenue Share by Type in 2019
Table Global Personalized Medicine and Epigenomics Revenue Forecast by Type (2019-2024)
Figure Global Personalized Medicine and Epigenomics Market Share Forecast by Type (2019-2024)
Figure Global Reagents Revenue Growth Rate (2014-2019)
Figure Global Kits Revenue Growth Rate (2014-2019)
Figure Global Instruments Revenue Growth Rate (2014-2019)
Figure Global Enzymes Revenue Growth Rate (2014-2019)
Figure Global Services Revenue Growth Rate (2014-2019)
Table Global Personalized Medicine and Epigenomics Revenue by Application (2014-2019)
Table Global Personalized Medicine and Epigenomics Revenue Share by Application (2014-2019)
Figure Global Personalized Medicine and Epigenomics Revenue Share by Application (2014-2019)
Figure Global Personalized Medicine and Epigenomics Revenue Share by Application in 2019
Table Global Personalized Medicine and Epigenomics Revenue Forecast by Application (2019-2024)
Figure Global Personalized Medicine and Epigenomics Market Share Forecast by Application (2019-2024)
Figure Global Oncology Revenue Growth Rate (2014-2019)
Figure Global Non-Oncology Revenue Growth Rate (2014-2019)
Figure Global Cancer Drug Technology Revenue Growth Rate (2014-2019)
Figure Global Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Personalized Medicine and Epigenomics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Personalized Medicine and Epigenomics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Personalized Medicine and Epigenomics Revenue Market Forecast (2019-2024)
Figure Europe Personalized Medicine and Epigenomics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Personalized Medicine and Epigenomics Revenue Market Forecast (2019-2024)
Figure South America Personalized Medicine and Epigenomics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Personalized Medicine and Epigenomics Revenue Market Forecast (2019-2024)


【掲載企業】

Abbott Laboratories、Affymetrix、Agilent Technologies、Astellas Pharmaceuticals、BAYER AG、Bio Vision、Celgene Corp.、Emd Millipore、Epigenomics AG、Epigentex、Envivo Pharmaceuticals (Forum Pharmaceutricals)、Gilead Sciences、Glaxosmithkline、Illumina Inc.、Johnson & Johnson、Karus Therapeutics Limited、Laboratory Corp. Of America Holdings、LES Laboratoires Servier、Merck、Naturewise Biotech & Medicals Corp.、Novartis Pharma AG、Oncolys Biopharma Inc.、Orchid Chemicals & Pharmaceuticals Limited、Progen Pharmaceuticals Limited、Quest Diagnostics、Roche Holding AG、Rubicon Genomics、Takeda Pharmaceutical Company Limited、

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ オーダメイド医療およびエピゲノミクスの世界市場2019(Global Personalized Medicine and Epigenomics Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • コネクテッドヘルスウェルネスデバイスの世界市場2019
  • 末梢神経損傷治療の世界市場2019
  • 特殊パルプの世界市場2019
  • 非侵襲的血行動態モニターの世界市場2019
  • 機械防振ゴムアイソレータマウントの世界市場2019
  • 楕円導波管の世界市場2019
  • アジテーターシールの世界市場2019
  • 熱転写フィルムの世界市場2019
  • 医薬品コールドチェーンの世界市場2019
  • トロリー搭載型理学療法多機能機器の世界市場2019
  • 無線周波数（RF）テスターの世界市場2019
  • 五フッ化ヨウ素（IF5）の世界市場2019
  • 脱脂漂白セラックの世界市場2019
  • 航空宇宙産業用フォースセンサーの世界市場2019
  • キーバリューストア（KVS）の世界市場2019